Figure 1From: Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and predictionClinical decision-making for adjuvant chemotherapy. Criteria included in the St. Gallen guidelines (green font) and in Adjuvant! Online (underlined) are shown. ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor; uPA/PAI-1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1.Back to article page